Clinical Trial Update: Apixaban or Enoxaparin After Head and Neck Cancer Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial comparing apixaban and enoxaparin for prevention of venous thromboembolism after head and neck cancer surgery. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Venous Thromboembolism

Drugs mentioned

• Apixaban (apixaban)
• Enoxaparin (enoxaparin sodium)

Snippet

Sponsor: Kiranya Arnold | Conditions: Venous Thromboembolism, Head and Neck Cancer | Phase 4 | Status: RECRUITING